---
title: "Gentian Diagnostics: Invitation to virtual presentation at 24 June"
description: Gentian Diagnostics ASA has the pleasure of inviting to a virtual presentation on Thursday 24 June 2021 at 10:00-11.00 am CEST
---

Gentian Diagnostics ASA has the pleasure of inviting to a virtual presentation  
on Thursday 24 June 2021 at 10:00-11.00 am CEST in relation with the company’s  
updated investor presentation and new long-term ambition (see separate stock exchange release earlier today).

Gentian’s CEO Hilja Ibert, CSO Erling Sundrehagen and CFO Njaal Kind will  
present the company followed by a Q&A session.

Join the online presentation via the following link:

[https://streams.eventcdn.net/gentian/company-presentation/](https://streams.eventcdn.net/gentian/company-presentation/) 

Questions can be submitted during the online webcast.

IR contact  
Njaal Kind, CFO  
[njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)   
+47 919 06 525 (mobile)

About Gentian Diagnostics  
Gentian Diagnostics (OSE: GENT), founded in 2001, develops and manufactures  
high-quality, in vitro diagnostic reagents. Gentian’s expertise and focus lies  
within immunochemistry, specifically infections, inflammations, kidney failures  
and congestive heart failures. By converting existing and clinically relevant  
biomarkers to the most efficient automated, high-throughput analysers, the  
company contributes to saving costs and protecting life. Gentian is based in  
Moss, Norway, serving the global human and veterinary diagnostics markets  
through sales and representative offices in Sweden, USA and China. For more  
information, please visit [www.gentian.com](https://www.gentian.com).

**More information:**  
[Access the news on Oslo Bors NewsWeb site](https://newsweb.oslobors.no/message/536323)

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-virtual-presentation-24-june#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-virtual-presentation-24-june#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-virtual-presentation-24-june#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)